| Financial Year |
March 31 2023 |
| Monetary Funds |
1,031,433,375.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,000,000.00 |
| Accounts Receivable |
14,356,848.22 |
| Advances to Suppliers |
3,666,689.17 |
| Other Receivables |
19,267,877.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,442,623,851.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,542,385.42 |
| Total Current Assets |
2,536,891,028.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
141,100.41 |
| Investment Properties |
-- |
| Fixed Assetes |
1,424,598,883.82 |
| Under-construction Projects |
489,328.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
197,020,247.92 |
| R&D expenses |
-- |
| Goodwill |
1,008,974.41 |
| Long-Term Deferred and Prepaid Expenses |
14,394,011.68 |
| Deferred Income Tax Assets |
22,167,443.98 |
| Other Non-Current Assets |
3,935,513.43 |
| Sub-Total of Non-Current Assets |
1,689,793,425.85 |
| Total Assets |
4,226,684,453.98 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
222,262,379.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,234,464.51 |
| Taxes Payable |
43,301,944.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,470,154.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,021,561.74 |
| Other Current Liabilities |
55,285,165.14 |
| Sub-Total of Current Liabilities |
848,853,195.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,958,671.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,975,367.95 |
| Total Liabilities |
891,828,563.23 |
| Paid-In Capital(Or Share Stock) |
507,259,997.00 |
| Capital Surplus |
870,917,109.16 |
| Surplus Reserve |
239,955,120.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,713,029,221.97 |
| Minority Stockholder's Interest |
3,694,441.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,331,161,448.92 |
| Owner's Equity（Stockholder's Equity） |
3,334,855,890.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,226,684,453.98 |
